Michael A. Solomon, MD, MBA

BS, Brown University
MD, New York University
MBA, Massachusetts Institute of Technology

Dr. Solomon is a senior staff member of both the Critical Care Medicine Department at the NIH Clinical Center and the Cardiovascular Branch of the National Heart, Lung, and Blood Institute (NHLBI).

He completed his undergraduate degree at Brown University and his medical degree at New York University School of Medicine. After a residency at University of Texas (UT) Southwestern Medical Center at Dallas, he completed a Critical Care Medicine fellowship at the NIH Clinical Center. He returned to UT Southwestern Medical Center to complete a second fellowship in Cardiovascular Diseases. Subsequently, he joined the cardiology faculty of UT Southwestern specializing in caring for patients with advanced heart failure, pulmonary hypertension and those receiving a heart transplant. He returned to NIH in 2000, receiving a joint appointment in both the Clinical Center's Critical Care Medicine Department and the Cardiovascular Branch of the NHLBI. He supervises clinical activities relating to the fields of critical care cardiology and pulmonary hypertension.

Dr. Solomon serves as the Vice-chair of the NIH Staff Clinician Council and the Chair of the NIH Pharmacy and Therapeutics Committee. He also serves as the Co-chair of the ACC Critical Care Cardiology Council.

Dr. Solomon's research interests include endothelial cell dysfunction and inflammation in pulmonary arterial hypertension, methods of detection of cardiac allograft cellular rejection, and organizational structures and outcomes in the delivery of critical care cardiology.

• NIH CC CEO Award 2020 & 2021
• NIH Director's Award, 2015
• Distinguished Service Award, American College of Cardiology Maryland Chapter, 2012
• NIH Principal Clinical Investigator, Bench-to-Bedside Award, 2011
• NIH Principal Clinical Investigator, Bench-to-Bedside Award, 2004

Jentzer JC, Wiley BM, Reddy YNV, Barnett C, Borlaug BA, and Solomon MA. Epidemiology and Outcomes of Pulmonary Hypertension in the Cardiac Intensive Care Unit. Eur Heart J Acute Cardiovasc Care, 11(3):230-241, 2022.

Lu M, Blaine KP, Cullinane A, Hall C, Dulau-Florea A, Sun J, Graninger GM, Harper BJ, Brusca SB, Elinoff JM, and Solomon MA. Pulmonary Arterial Hypertension Patients Display Normal Kinetics of Clot Formation. Pulm Circ, 11(3): 1-9, 2021.

Jentzer JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, Kashani K, Kazory A, Kellum JA, Mao M, Moriyama B, Morrow DA, Patel H, Rali AK, van Diepen S, and Solomon MA for the Critical Care Cardiology Working Group of the Heart Failure and Transplant Section. Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome. J Am Coll Cardio, 76(9): 1084-1101, 2020.

Elinoff JM, Mazer AJ, Cai R, Lu M, Graninger GM, Harper BJ, Ferreyra G, Sun J, Solomon MA*, and Danner RL*. Meta-analysis of Blood Genome-Wide Expression Profiling Studies in Pulmonary Arterial Hypertension. Am J Physiol Lung Cell Mol Physiol, 318(1): L98-L111, 2020 *Denotes Contributed Equally.

Brusca SB, Barnett C, Barnhart BJ, Weng W, Morrow DA, Soble JS, Katz JN, Wiley BM, van Diepen S, Gomez AD, and Solomon MA. The Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses from Dual Certified Critical Care Cardiologists. Journal of the American Heart Association, 8(6): https://doi.org/10.1161/JAHA.118.011721 2019.

Alviar CL+, Miller PE+, van Diepen S, Katz JN, Soble JS, Lee B, Moriyama B, McAreavey D, Solomon MA*, and Morrow DA*. A Guide to Positive Pressure Ventilation in the Cardiac Intensive Care Unit: Perspectives from the ACC Critical Care Cardiology Working Group. J Am Coll Cardiol. 72(13): 1532-1553, 2018. +*Denotes Contributed Equally.

Elinoff JM, Agarwal R, Barnett CF, Benza RL, Cuttica MJ, Gharib AM, Gray MP, Hassoun PM, Hemnes AR, Humbert M, Kolb TM, Lahm Y, Leopold JA, Mathai SC, McLaughlin VV, Preston IR, Rosenzweig EB, Shlobin OA, Steen VD, Zamanian RT, and Solomon MA. Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. Am J Respir Crit Care Med, 198(2): 166-174, 2018.

Elinoff JM, Chen LY, Dougherty EJ, Awad KS, Wang S, Biancotto A, Siddiqui AH, Weir NA, Cai R, Sun J, Preston I, Solomon MA, and Danner RL. Spironolactone-induced Degradation of the TFIIH Core Complex Helicase Subunit Suppresses NF-kappa-B and AP-1 Signaling. Cardiovascular Research, 114(1): 65-76, 2018.

Sachdev V, Solomon MA, and Masur H. Does HIV Really Augment the Frequency or Mortality Risk of Increased Pulmonary Artery Systolic Pressures? Am J Respir Crit Care Med, 197(7): 854-55, 2018.

Agbor-Enoh ST, Tunc I, De Vlaminck I, Fideli U, Davis A, Cuttin K, Bhatti K, Marista A, Solomon MA, Jackson A, Graninger G, Harper B, Luikart H, Wylie J, Wang X, Khush K, Zhu J, and Valantine HA. Applying Rigor and Reproducibility Standards to Assay Donor-Derived Cell-Free DNA as a Non-Invasive Method for Detection of Acute Rejection and Graft Injury after Heart Transplantation. Journal of Heart & Lung transplantation, 36(9): 1004-12, 2017.

van Diepen S, Fordyce CB, Wegermann Z, Granger CB, Stebbins A, Morrow DA, Solomon MA, Soble J, Henry TD, Gilchrist IC, Katz JN, Cohen MG, and Newby LK. Organizational Structure, Staffing, Resources, and Educational Initiatives in Cardiac Intensive Care Units in the United States:  An American Heart Association Acute Cardiac Care Committee and American College of Cardiology Critical Care Cardiology Working Group Cross-Sectional Survey. Circulation: Cardiovascular Quality and Outcomes, 10 (8): e003864, 2017.

Miller PE, Solomon MA, and McAreavey D. Advanced Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. Critical Care Medicine, 45(11): 1922-29, 2017.

Awad KS, Elinoff JM, Wang S, Gairhe S, Ferreyra GA, Cai R, Sun J, Solomon MA, and Danner RL. Raf/ERK Drives the Proliferative and Invasive Phenotype of BMPR2-Silenced Pulmonary Artery Endothelial Cells. Am J Physiol Lung Cell Mol Physiol, 310(2): L187-201, 2016.

Tropea MM, Harper BJA, Graninger GM, Phillips TM, Ferreyra G, Mostowski H, Danner RL, Suffredini AF, and Solomon MA. Isolation of a Circulating CD45-, CD34dim Cell Population and Validation of their Endothelial Origin. Thrombosis and Haemostasis, 112(4): 770-80, 2014.

Elinoff JM, Forfia PR, Hall MK, Sun J, Gharib A, Abd-Elmoniem K, Graninger G, Harper B, Danner RL, and Solomon MA. A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension. Trials, 14:91, 2013.

Chen H, Mei Yun-qing, and Solomon, MA. Experiences of Establishing a Rat Abdominal Heart Transplantation Model. National Medical Journal of China, 92(24):1715-18, 2012.

Amarnath S, Chen H, Foley JE, Costanzo CM, Sennesh JD, Solomon MA, and Fowler DH. Host-Based Th2 Cell Therapy for Prolongation of Cardiac Allograft Viability. PloS ONE, 6(4): e18885, 2011.

Deans KJ, Minneci PC, Chen H, Kern SJ, Logun C, Alsaaty S, Norsworthy KJ, Theel SM, Sennesh JD, Barb JJ, Munson PJ, Danner RL, Solomon MA. Impact of Animal Strain on Gene Expression in a Rat Model of Acute Cardiac Rejection. BMC Genomics, 10: 280, 2009.

Solomon SB, Minneci PC, Deans KJ, Feng J, Eichacker PQ, Banks SM, Danner RL, Natanson C, Solomon MA. Effects of Intra-Aortic Balloon Counterpulsation in a Model of Septic Shock. Critical Care Medicine, 37(1):7-18, 2009.

Desai, A, Glaser, A, Liu, D, Raghavachari, N, Blum, A, Zalos, G, Lippincott, M, McCoy, JP, Munson, PJ, Solomon, MA, Danner, RL, Cannon, RO. Microarray-Based Characterization of a Colony Assay used to Investigate Endothelial Progenitor Cells and Relevance to Endothelial Function in Humans. Arterioscler Thromb Vasc Biol, 29, 121-127, 2009.

Elshal MF, Khan SS, Raghavachari N, Takahashi Y, Barb J, Bailey JJ, Munson PJ, Solomon MA, Danner RL, McCoy JP. A Unique Population of Effector Memory Lymphocytes Identified by CD146 having a Distinct Immunophenotypic and Genomic Profile. BMC Immunology, 8:29, 2007.

Visit PubMed.gov for a full list of Dr. Solomon's publications.